Compliance Program

Ferndale Pharma Group, Inc. has established and maintains a Comprehensive Compliance Program that is designed to comply with applicable federal and state laws and industry standards relating to the marketing and promotion of our products. Specifically, the program has been designed in accordance with the Office of Inspector General of the Department of Health and Human Services April 2003 Compliance Program Guidance for Pharmaceutical Manufacturers (“OIG Guidelines”) and includes policies for compliance with the Pharmaceutical Research and Manufacturers of America July 2009 Code on Interactions with Healthcare Professionals (“PhRMA Code”).

With a long-standing commitment to ethics and good corporate citizenship, Ferndale Pharma Group, Inc.’s well-established compliance program:

• is consistent with recommendations set forth by the US Department of Health and Human Services and the Code on Interactions with Healthcare Professionals created by the Pharmaceutical Research and Manufacturers of America (PhRMA)
• seeks to prevent, detect, and resolve potential violations of law or company policy
• undergoes regular assessment and adjustment to make sure we are being responsive to evolving business and associated compliance risks

Our compliance program is just one part of our overall commitment to our stakeholders.